Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Jacobs

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 5, 2002
The impact of chronic obstructive pulmonary disease on work loss in the United StatesDon D Sin, Tania Stafinski, Ying Chu Ng, et al.
The Canadian Journal of Cardiology|December 13, 2005
Economic implications of treatment guidelines for congestive heart failureMarcelo C Shibata, Carolyn Nilsson, Marilou Hervas-Malo, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 6, 2002
Dilatation and curettage: praxeologyDavid Cumming, Arif Alibhai, Danny Robson, et al.
International Journal of Law and Psychiatry|May 30, 2016
Mental health services costs within the Alberta criminal justice systemPhilip Jacobs, Jessica Moffatt, Carolyn S Dewa, et al.
Psychiatric Services (Washington, D.C.)|May 5, 2009
Disability payments for persons with severe mental illness in Alberta, CanadaRaymond Block, Mel Slomp, Scott Patten, et al.
Canadian Respiratory Journal|March 21, 2007
The cost of lung cancer in AlbertaSandor J Demeter, Philip Jacobs, Chester Chmielowiec, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 4, 2017
The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical TrialsDat T Tran, Ilke Akpinar, Richard Fedorak, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 18, 2012
The distribution of mental health service costs for depression in the Alberta populationMel Slomp, Philip Jacobs, Arto Ohinmaa, et al.
Chronic Diseases in Canada|May 5, 2006
A population-based analysis of health behaviours, chronic diseases and associated costsArto Ohinmaa, Donald Schopflocher, Philip Jacobs, et al.
Breast Cancer Research and Treatment|April 30, 2008
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effectsHeather-Jane Au, Kamran Golmohammadi, Tallal Younis, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
American Journal of Respiratory and Critical Care Medicine|March 5, 2002
The impact of chronic obstructive pulmonary disease on work loss in the United StatesDon D Sin, Tania Stafinski, Ying Chu Ng, et al.
The Canadian Journal of Cardiology|December 13, 2005
Economic implications of treatment guidelines for congestive heart failureMarcelo C Shibata, Carolyn Nilsson, Marilou Hervas-Malo, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 6, 2002
Dilatation and curettage: praxeologyDavid Cumming, Arif Alibhai, Danny Robson, et al.
International Journal of Law and Psychiatry|May 30, 2016
Mental health services costs within the Alberta criminal justice systemPhilip Jacobs, Jessica Moffatt, Carolyn S Dewa, et al.
Psychiatric Services (Washington, D.C.)|May 5, 2009
Disability payments for persons with severe mental illness in Alberta, CanadaRaymond Block, Mel Slomp, Scott Patten, et al.
Canadian Respiratory Journal|March 21, 2007
The cost of lung cancer in AlbertaSandor J Demeter, Philip Jacobs, Chester Chmielowiec, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 4, 2017
The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical TrialsDat T Tran, Ilke Akpinar, Richard Fedorak, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 18, 2012
The distribution of mental health service costs for depression in the Alberta populationMel Slomp, Philip Jacobs, Arto Ohinmaa, et al.
Chronic Diseases in Canada|May 5, 2006
A population-based analysis of health behaviours, chronic diseases and associated costsArto Ohinmaa, Donald Schopflocher, Philip Jacobs, et al.
Breast Cancer Research and Treatment|April 30, 2008
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effectsHeather-Jane Au, Kamran Golmohammadi, Tallal Younis, et al.
Pageof 14